AI-Designed Drug Shows Promising Results in Biological Aging Research 2026
Artificial intelligence is rapidly changing modern medicine. Its use has become especially important in drug discovery. In 2026, promising findings were reported about an AI-Designed Drug called rentosertib. The drug was originally developed for idiopathic pulmonary fibrosis (IPF). IPF is a serious lung disease that causes progressive scarring of lung tissue. Interestingly, its possible effects…